BofA Securities Downgrades Doximity Inc (DOCS) to Underperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts DOCS Hot Sheet
Price: $34.67 +6.35%
Rating Summary:
10 Buy, 13 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
10 Buy, 13 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
BofA Securities analyst Allen Lutz downgraded Doximity Inc (NYSE: DOCS) from Neutral to Underperform with a price target of $29.00 (from $43.00).
For an analyst ratings summary and ratings history on Doximity Inc click here. For more ratings news on Doximity Inc click here.
Shares of Doximity Inc closed at $40.31 yesterday.
You May Also Be Interested In
- Raymond James Double Downgrades Aardvark Therapeutics Inc (AARD) to Market Perform
- Insulet Corporation (PODD) PT Raised to $200 at Jefferies
- Zimmer Biomet (ZBH) PT Raised to $125 at Stifel
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
